Aclaris Therapeutics (ACRS) Other Non Operating Income (2016 - 2024)

Aclaris Therapeutics' Other Non Operating Income history runs 9 years deep, the most recent figure standing at $1.9 million for Q2 2024.

• On a quarterly basis, Other Non Operating Income fell 16.83% year-over-year to $1.9 million in Q2 2024; TTM through Jun 2024 was $8.4 million, a 31.29% increase from a year earlier, with the FY2023 full-year figure at $8.5 million, up 188.83% from the prior year.
• Other Non Operating Income declined to $1.9 million in Q2 2024 per ACRS's latest filing, from $2.0 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $2.3 million in Q3 2023 and bottomed at -$851000.0 in Q3 2021.
• The 5-year median for Other Non Operating Income is $320000.0 (2020), against an average of $763722.2.
• Across the five-year window, Other Non Operating Income tumbled 338.66% in 2021 and soared 1522.47% in 2022, its largest moves.
• Year by year, Other Non Operating Income stood at -$219000.0 in 2020, then jumped by 140.64% to $89000.0 in 2021, then soared by 1522.47% to $1.4 million in 2022, then soared by 51.59% to $2.2 million in 2023, then slipped by 14.66% to $1.9 million in 2024.
• Per Business Quant, the three latest ACRS Other Non Operating Income figures stand at $1.9 million (Q2 2024), $2.0 million (Q1 2024), and $2.2 million (Q4 2023).